Basic Information
BetaGlue Therapeutics is a clinical-stage oncology company that has developed an advanced radiation therapy platform capable of locally targeting unresectable solid tumors and surgical margins, known as YntraDose.
Enterprise Profile
Industrial Sector
Concept
Application Scenarios